From “ACAN” to “I CAN”: Restoring wellness in a boy with severe osteochondritis dissecans through diagnostic precision combined with optimal medical, surgical and rehabilitation management

[1]  Jeffery A Taylor-Haas,et al.  Clinical phenotype and musculoskeletal characteristics of patients with aggrecan deficiency , 2022, American journal of medical genetics. Part A.

[2]  V. Hwa,et al.  Treatment of Short Stature in Aggrecan Deficient Patients with Recombinant Human Growth Hormone: One-Year Response. , 2021, The Journal of clinical endocrinology and metabolism.

[3]  Philippe M. Campeau,et al.  Variable expressivity in a family with an aggrecanopathy , 2021, Molecular genetics & genomic medicine.

[4]  I. Rabbone,et al.  Retrospective Diagnosis of a Novel ACAN Pathogenic Variant in a Family With Short Stature: A Case Report and Review of the Literature , 2021, Frontiers in Genetics.

[5]  D. Umebayashi,et al.  Symptomatic Chiari type 1 malformation associated with acromegaly: A case report , 2021, Surgical neurology international.

[6]  D. Rosenzweig,et al.  The Link between Aggrecan and Familial Osteochondritis Dissecans , 2021, Surgeries.

[7]  Guramrit Singh,et al.  The Branched Nature of the Nonsense-Mediated mRNA Decay Pathway. , 2020, Trends in genetics : TIG.

[8]  R. Elwy,et al.  Effects of growth hormone therapy in pediatric patients with growth hormone deficiency and Chiari I malformation: a retrospective study , 2019, Child's Nervous System.

[9]  A. Kothari,et al.  Juvenile osteochondritis dissecans (JOCD) of the knee: current concepts review , 2019, EFORT open reviews.

[10]  S. Zaffagnini,et al.  Osteochondritis Dissecans of the Knee: Etiology and Pathogenetic Mechanisms. A Systematic Review , 2018, Cartilage.

[11]  D. Larson,et al.  Incidence of symptomatic osteochondritis dissecans lesions of the knee: a population-based study in Olmsted County. , 2017, Osteoarthritis and cartilage.

[12]  S. Lalani,et al.  Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations , 2017, The Journal of clinical endocrinology and metabolism.

[13]  Laura A. Treadgold,et al.  Amalgamated Reference Data for Size‐Adjusted Bone Densitometry Measurements in 3598 Children and Young Adults—the ALPHABET Study , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[15]  Luca Monti,et al.  Alteration of proteoglycan sulfation affects bone growth and remodeling , 2013, Bone.

[16]  M. O’Grady,et al.  Symptomatic Chiari 1 malformation after initiation of growth hormone therapy. , 2011, The Journal of pediatrics.

[17]  Takako Sasaki,et al.  A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans. , 2010, American journal of human genetics.

[18]  R. Davey,et al.  Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis. , 2005, Health Technology Assessment.

[19]  C. Little,et al.  Mechanisms involved in cartilage proteoglycan catabolism. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[20]  E. Rappaport,et al.  Effects of exogenous growth hormone on growth plate cartilage in rats. , 1987, A M A Journal of Diseases of Children.